Skip to main content
. 2008 Oct 8;2008(4):CD006268. doi: 10.1002/14651858.CD006268.pub2

Pohlmann 1993.

Methods Single center, randomised, controlled trial 
 1) Allocation concealment: Unclear/Not stated 
 2) Blinding of patients: Yes 
 3) Blinding of outcome assessors: No 
 4) A priori calculation of sample size: Unclear/Not stated 
 5) Groups treated identical other than the named intervention: Unclear/Not stated
Participants Number of eligible patients: Not stated 
 Number of patients enrolled: 102 
 Drop outs/Withdrawals: 3 
 Incl. Criteria: In‐patients, who were 18 years of age or older 
 Excl. Criteria: Serious unrelated medical diseases 
 Country: Germany 
 Setting: Inpatient 
 Age(mean)(yrs): Group A: 55 Group B: 62 
 N (%) males: Group A: 21 (43) Group B: 25(50) 
 ASA score: Not stated 
 Groups comparable at baseline: Yes (age, sex ratio)
Interventions Group A (n=49): Propofol: Initial bolus 2.5 mg/kg body weight (for participants 18‐50 years age), 1.7 mg/kg (51‐74 years) or 1.1 mg/kg (75‐93 years). Subsequent infusion 6 mg/kg/hr (18‐50 years ), 4.5 mg/kg/hr (51‐74 years) or 3.8 mg/kg/hr (75‐93 years) 
 Group B (n=50): Midazolam: Maximum dose 12.5 mg 
 Mode of administration: Propofol: bolus followed by infusion Midazolam: bolus 
 Administration directed by endoscopist 
 Goal level of sedation: Slurred speech or lack of reaction (no response to verbal commands) 
 Supplemental oxygen (2 L/min through nasal cannula) administered if oxygen saturation dropped to <90% for more than 1 min
Outcomes Patients' level of sedation, pain, ability to cooperate, acceptability of procedure, antegrade amnesia, complications (a decline in oxygen saturation, drop in systolic and diastolic pressure, apnea)
Notes German language article 
 Patients likely blinded, although not explicitly stated in the study. It was stated that the study was single blinded. 
 Withdrawals: Data from three patients (2 in propofol group and 1 in midazolam) were not analysed in the study as they had to be given more than the prescribed medications 
 Definitions: 
 1) Patients' level of sedation: assessed after the initial bolus injection as awake, somnolent (reaction to verbal command) and asleep 
 2) Patients' ability to cooperate and acceptability of procedure graded by the endoscopists, immediately after the colonoscopy, on a 10 point scale 
 3) Pain: Patients asked ( 4 hrs after the procedure) to rate their pain during the procedure on a 10 point scale 
 4) Mean (and range) drop in systolic, diastolic pressures and O2 saturation provided